Federal marijuana reclassification could reshape medical research and cannabis industry
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustryAging Clinical Summary The potential federal reclassification of marijuana from Schedule I to a…
Justice Department, DEA ordered to reclassify state-licensed medical cannabis as less … – Maui Now
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchSafety Clinical Summary A federal court has ordered the Department of Justice and DEA to reclassify…
Cannabis Use and Falls in Elderly: New Trauma Center Data – CED Clinic
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. AgingSafetyResearchNeurology Why This Matters # Why This Matters ClinicallyClinicians treating elderly patients need…
Elevated Cannabis Use Tied to Higher Anxiety and Symptom Burden in Opioid Use Disorder Patients
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. AnxietyMental HealthResearchSafety Why This Matters Clinicians treating patients with opioid use disorder on…
What Federal Cannabis Rescheduling Means for Care
Cannabis Schedule III rescheduling marks a major shift in how cannabis is classified and understood at the federal level. This change begins to align policy with clinical reality, affecting research, documentation, and patient access. Cannabis Schedule…
Beyond Epilepsy Control: Repurposing Antiepileptic Drugs in Central Nervous System Tumor Therapy.
A comprehensive review explores cannabidiol brain tumor antiepileptic mechanisms and suggests potential antitumor activity in CNS cancers. The analysis identifies multiple pathways through which CBD and other antiepileptic drugs might combat brain tumors…
Opioid Use Disorder Among Cervical Fusion Inpatients: Trends, Complications, and Resource Use in a Retrospective National Inpatient Sample Analysis, 2016-2022.
A large retrospective study reveals that opioid use disorder affects 3.4% of cervical fusion surgery patients, with these individuals experiencing significantly longer hospital stays and higher complication rates. This population-level data provides…
The cannabidiol (CBD): Tetrahydrocanabinol (THC) concentration ratio is critical for neuroprotection and recovery following traumatic brain injury.
Preclinical research demonstrates that specific CBD THC ratio neuroprotection mechanisms outperform CBD isolate in traumatic brain injury models. This study supports the entourage effect hypothesis while highlighting the need for human clinical trials to…
12-Month Patient-Reported Outcomes Among Urine Toxicology-Identified Substance Users After Elective Spine Surgery: A Prospective Longitudinal Cohort Study.
While prior studies have examined the role of opioids, alcohol, and marijuana use on early postoperative outcomes after elective spine surgery, longitudinal ...
Fear of recurrence, secondary cancers, and health problems in long-term survivors of childhood cancer: Findings from a Canadian cohort.
Survivors of childhood cancer are at lifelong risk for health problems, secondary cancers, and recurrence. However, little is known about their fears related...